NCT05198765Active, not recruiting
Weight Loss Clinical Decision Support
Reducing Clinical Inertia in Obesity Management of Diabetes Patients in Primary Care: Cluster-Randomized Trial
Source: ClinicalTrials.gov · Last updated 21 Sept 2026
Brief summary (registry, in English)
Despite steady increases in obesity prevalence, the more than 12 million obese U.S. adults with type 2 diabetes (T2DM) and severe obesity encounter a number of barriers to adopting effective surgical and pharmaceutical treatments, including: (a) both patients and primary care clinicians frequently underestimate the effectiveness and potential benefits of obesity treatments; and (b) both patients and clinicians typically lack access to evidence-based estimates of the patient-specific potential benefits and risks of appropriate obesity treatment options. This project addresses these important obstacles to evidence-based obesity care by providing accurate, patient-specific estimates of benefits and risks of various obesity treatment options to inform shared decision making about obesity treatment. In this project the study team will implement a scalable, web-based point-of-care decision-support intervention in primary care that provides patient-specific estimates of obesity treatment benefits and risks in a randomized trial in 40 primary care clinics with 15,810 eligible patients, and assess intervention impact on (i) appropriate active management of obesity in eligible patients, (ii) weight trajectories, and (iii) patient and clinician satisfaction with the decision support intervention.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 10120 (estimated)
- First submitted
- 20 Dec 2021
- Start date
- 19 Apr 2023
- Primary completion date
- 31 Oct 2025
- Lead sponsor
- HealthPartners Institute
- Diseases
- Obesity, Type 2 diabetes
- NCT number
- NCT05198765
What you commit to
- Study type: Interventional
- Planned participants: 10120
- From 19 Apr 2023 to the primary completion date, 31 Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior MBS
Other illness
- Patients diagnosed with cancer (except non-melanoma skin cancer), dementia, and/or cirrhosis.
Other
- Pregnant or breastfeeding.
- In long-term care, palliative care, or hospice care.
Who the study is looking for
- Adults (age 18-75 years at index clinical encounter)
- Existing diagnosis of T2DM
- BMI ≥35 kg/m2 at index clinical encounter
- Have an index clinical encounter with a PCC (family practice or general internal medicine physician, nurse practitioner, or physician assistant) at a randomized study clinic during a 12-month accrual period
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| HealthPartners Medical Group Coordinator of this site? Confirm its status | Minneapolis | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.